Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related FOE
Mid-Afternoon Market Update: Evoke Pharma Drops On Failed Phase 3 EVK-001 Data; ParkerVision Shares Spike Higher
12 Biggest Mid-Day Losers For Monday

Analysts at Monness Crespi downgraded Ferro (NYSE: FOE) from “buy” to “neutral.” Ferro's shares closed at $4.04 on Friday. Ferro's trailing-twelve-month operating margin is 1.83%.

Latest Ratings for FOE

Nov 2017KeyBancMaintainsOverweight
Oct 2017KeyBancMaintainsBuy
Jul 2017Deutsche BankMaintainsBuy

View More Analyst Ratings for FOE
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (FOE)

View Comments and Join the Discussion!